America's Top Tradeshow Directory | Events In America
Facebook Linked In Twitter Videos

Event Contacts

Andrew Juurinen
Xtalks Webinars
1235 Bay Street, Suite 802
Toronto, ON M6G 1X5
(416) 977-6555

Event Description

Study of rare cancers tends to look more like rare disease research than standard oncology research. This webinar will highlight some of the challenges in designing and conducting trials for rare cancers and explore positions adopted by various authors and research consortia on how to best design and conduct these trials, including a review of pending legislation — the 21st Century Cures Act — and how it might affect rare oncology research if passed.

Considerations include recruiting patients with rare cancers, maximizing the value of data points in clinical trials involving small populations, potential use of adaptive design in these trials, and the appetite for risk among researchers and patients.

Typically in oncology trials, and similarly in rare disease trials, the investigational product is tested only on affected subjects rather than on healthy volunteers. Testing new drugs on this vulnerable population requires consideration of the study design so the fewest possible subjects are exposed to the investigational product, and so the study yields information that supports viable research decisions.

As the cost of clinical trials rises along with the cost of bringing new drugs to market, research should include alternative study design approaches and emphasize early indicators such as biomarkers, natural history data, and preclinical data. This approach also reduces the patient burden and may accelerate drug development timelines.

Don't wait to register for the Rare Oncology Research in the 21st Century. You'll meet influential people and maximize your opportunities for success. Start now by accessing the information below.

All information in Events In America is deemed to be accurate at the time we add it, and we take steps to verify all details and update our records when new information is provided, but as people, events and circumstances change, we caution users to independently confirm all information. and Events In America LLC make no guarantee of accuracy and assume no liability for inaccurate information.

Event Details

Conference/Event Dates: 03/29/2016 - 03/29/2016
Classification: B2B
Primary Industry: Oncology-Hematology
Other Industries: Cancer, Clinical Pharmacology, Oncology-Hematology, Professional Healthcare
Audience: VPs, Directors, Managers, Department Heads, Scientists and Researchers working within:

Clinical Affairs
Clinical R&D
Clinical Research
Clinical Pharmacology
Clinical Operations
Project Management
Regulatory Affairs
Medical Affairs

for pharmaceutical, biotechnology and medical device companies.

Booth Details

Booth Size Booth Cost   Available Amenities
No exhibiting.   Electricity: n/a
  Water: n/a
  Generator: n/a
  Marketing Vehicles Allowed: n/a
Other Booth Sizes Available: n/a

Advance Networking

How do I show up here?
Mark Travers

Personal Notes

Add a note here, it is only visible by you.

New Search Contact This Event
Rare Oncology Research in the 21st Century

exhibitor lists